Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)

NCT ID: NCT00814099

Last Updated: 2015-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

2449 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

People with acute respiratory failure usually require the use of an artificial breathing machine, known as a mechanical ventilator. Sedative medications, which help keep people calm and reduce anxiety, are often prescribed for children who are on mechanical ventilators. However, the longer that sedative medications are used, the longer a child may need to remain on mechanical ventilation. This study will evaluate the effectiveness of a team approach to sedation management that aims to reduce the number of days that children with acute respiratory failure require mechanical ventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

People who are hospitalized for acute respiratory failure are typically supported on mechanical ventilation, which delivers oxygen and a continuous level of pressure to the damaged lungs. Over 90% of infants and children supported on mechanical ventilation receive some form of sedation medication, which helps keep them safe, calm, and comfortable. Unfortunately, the use of sedation medications may prolong the duration of mechanical ventilation, which can lead to an increased risk for pneumonia and other complications.

Recent studies among adults in intensive care units (ICUs) have shown that when doctors and nurses work together as a team to manage the use of sedation medication, patients are taken off mechanical ventilation sooner and with fewer side effects. This team strategy includes the following:

* Training and discussion between doctors and nurses regarding which sedative medications should be used
* Having doctors and nurses jointly identify the patient's progress and a daily sedation medication goal for the patient
* Having nurses use a decision-making tool to help guide changes in a patient's sedative medication dose
* Keeping track of patient care, which allows doctors and nurses to evaluate the effectiveness of how they manage each patient's sedative medication use

This study will examine the use of the sedation management strategy for infants and children in pediatric ICUs who have acute respiratory failure and require mechanical ventilation. The purpose of the study is to evaluate whether this team approach to sedation medication management is more effective than the usual approach at reducing the amount of time children remain on mechanical ventilators. Study researchers will also examine the cost-effectiveness of this approach and associated quality of life factors.

All participants will be enrolled within 24 hours of starting mechanical ventilation and will be monitored until they receive their last dose of sedative medication, hospital discharge, or Day 28 (whichever comes first). During a 3-month baseline period, all participating pediatric ICUs will provide their usual sedation management, and study researchers will review participants' medical records on a daily basis. Each pediatric ICU will then be randomly assigned to either the control group or the team approach group. Pediatric ICUs in the control group will continue to provide usual care for sedation management. Pediatric ICUs in the team approach group will implement the team approach sedation management guidelines. For both groups, pain and sedation levels will be monitored daily, and study researchers will review participants' medical records on a daily basis, too. Six months after hospital discharge, half of the participants and their parents will complete a follow-up survey and take part in a telephone interview to assess quality of life, psychological factors, and health-related resource use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Insufficiency Respiratory Distress Syndrome, Newborn Lung Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Participants will receive care at a pediatric ICU that is continuing the usual approach to sedation management.

Group Type ACTIVE_COMPARATOR

Usual approach to sedation management

Intervention Type BEHAVIORAL

The pediatric ICU will continue its usual approach to sedation management.

2

Participants will receive care at a pediatric ICU that is implementing the team approach to sedation management.

Group Type EXPERIMENTAL

Team approach to sedation management

Intervention Type BEHAVIORAL

The team approach to sedation management includes the following:

* Team education and consensus on the use of sedatives
* Team identification of the patient's trajectory of illness and daily prescription of a sedation goal
* A nurse-implemented goal-directed comfort algorithm that guides moment-to-moment titration of opioids and benzodiazepines
* Team feedback on sedation management performance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Team approach to sedation management

The team approach to sedation management includes the following:

* Team education and consensus on the use of sedatives
* Team identification of the patient's trajectory of illness and daily prescription of a sedation goal
* A nurse-implemented goal-directed comfort algorithm that guides moment-to-moment titration of opioids and benzodiazepines
* Team feedback on sedation management performance

Intervention Type BEHAVIORAL

Usual approach to sedation management

The pediatric ICU will continue its usual approach to sedation management.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 2 weeks of age (and at least 42 weeks post-menstrual age) and less than 18 years of age
* Intubated and mechanically ventilated for acute lung disease

Exclusion Criteria

* Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt
* History of single ventricle at any stage of repair
* Congenital diaphragmatic hernia or paralysis
* Primary pulmonary hypertension
* Critical airway or anatomical obstruction of the lower airway
* Ventilator dependent upon pediatric ICU admission
* Neuromuscular respiratory failure
* Spinal cord injury above the lumbar region
* Pain managed by patient-controlled analgesia or epidural catheter
* Patient transferred from an outside ICU where sedatives had already been administered for more than 24 hours
* Family or medical team has decided not to provide full support
* Enrolled in any other critical care interventional clinical trial concurrently or in the 30 days before study entry
* Known allergy to any of the study medications
* Pregnancy
Minimum Eligible Age

2 Weeks

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martha A.Q. Curley, RN, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

David Wypij, PhD

Role: STUDY_DIRECTOR

Director, Statistics and Data Coordinating Center; Children's Hospital Boston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital of Alabama

Birmingham, Alabama, United States

Site Status

University Medical Center, The University of Arizona

Tucson, Arizona, United States

Site Status

Children's Hospital and Research Center at Oakland

Oakland, California, United States

Site Status

Children's Hospital of Orange County

Orange, California, United States

Site Status

Lucile Salter Packard Children's Hospital at Stanford

Palo Alto, California, United States

Site Status

University of California Davis Medical Center

Sacramento, California, United States

Site Status

Children's Hospital at University of California San Francisco Medical Center

San Francisco, California, United States

Site Status

Connecticut Children's Medical Center

Hartford, Connecticut, United States

Site Status

Yale-New Haven Children's Hospital

New Haven, Connecticut, United States

Site Status

Nemours/Alfred I. duPont Hospital for Children

Wilmington, Delaware, United States

Site Status

Holtz Children's Hospital

Miami, Florida, United States

Site Status

Florida Hospital for Children

Orlando, Florida, United States

Site Status

Children's Memorial Hospital, Chicago

Chicago, Illinois, United States

Site Status

Advocate Hope Children's Hospital

Oak Lawn, Illinois, United States

Site Status

University of Maryland Hospital for Children

Baltimore, Maryland, United States

Site Status

Johns Hopkins Children's Center

Baltimore, Maryland, United States

Site Status

University of Massachusetts Memorial Children's Medical Center

Worcester, Massachusetts, United States

Site Status

C. S. Mott Children's Hospital of the University of Michigan

Ann Arbor, Michigan, United States

Site Status

Children's Mercy Hospital, Kansas City

Kansas City, Missouri, United States

Site Status

St. Louis Children's Hospital

St Louis, Missouri, United States

Site Status

University of Nebraska Medical Center

Omaha, Nebraska, United States

Site Status

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

Cohen Children's Medical Center of New York

New Hyde Park, New York, United States

Site Status

The Children's Hospital at Montefiore

The Bronx, New York, United States

Site Status

Duke Children's Hospital and Health Center

Durham, North Carolina, United States

Site Status

Doernbecher Children's Hospital

Portland, Oregon, United States

Site Status

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

Site Status

Monroe Carell, Jr. Children's Hospital at Vanderbilt

Nashville, Tennessee, United States

Site Status

Medical City Children's Hospital

Dallas, Texas, United States

Site Status

Children's Medical Center Dallas

Dallas, Texas, United States

Site Status

Primary Children's Medical Center

Salt Lake City, Utah, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Tasker RC. Respiratory Support for Bronchiolitis Management in the PICU: What We Now Know and What We Want to Know. Pediatr Crit Care Med. 2025 Jun 1;26(6):e827-e831. doi: 10.1097/PCC.0000000000003765. Epub 2025 Jun 5. No abstract available.

Reference Type DERIVED
PMID: 40471056 (View on PubMed)

Fischer M, Ngendahimana DK, Watson RS, Schwarz AJ, Shein SL. Cognitive, Functional, and Quality of Life Outcomes 6 Months After Mechanical Ventilation for Bronchiolitis: A Secondary Analysis of Data From the Randomized Evaluation of Sedation Titration for Respiratory Failure Trial ( RESTORE ). Pediatr Crit Care Med. 2024 Mar 1;25(3):e129-e139. doi: 10.1097/PCC.0000000000003405. Epub 2023 Dec 1.

Reference Type DERIVED
PMID: 38038620 (View on PubMed)

Olszewski AE, Dervan LA, Smith MB, Asaro LA, Wypij D, Curley MAQ, Watson RS. Risk Factors for Positive Post-Traumatic Stress Disorder Screening and Associated Outcomes in Children Surviving Acute Respiratory Failure: A Secondary Analysis of the Randomized Evaluation of Sedation Titration for Respiratory Failure Clinical Trial. Pediatr Crit Care Med. 2023 Mar 1;24(3):222-232. doi: 10.1097/PCC.0000000000003150. Epub 2022 Dec 23.

Reference Type DERIVED
PMID: 36728954 (View on PubMed)

Monteiro ACC, Flori H, Dahmer MK, Sim MS, Quasney MW, Curley MAQ, Matthay MA, Sapru A; BALI Study Investigators of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Thrombomodulin is associated with increased mortality and organ failure in mechanically ventilated children with acute respiratory failure: biomarker analysis from a multicenter randomized controlled trial. Crit Care. 2021 Aug 3;25(1):271. doi: 10.1186/s13054-021-03626-1.

Reference Type DERIVED
PMID: 34344416 (View on PubMed)

Kopp W, Gedeit RG, Asaro LA, McLaughlin GE, Wypij D, Curley MAQ; Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) Study Investigators. The Impact of Preintubation Noninvasive Ventilation on Outcomes in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med. 2021 May 1;49(5):816-827. doi: 10.1097/CCM.0000000000004819.

Reference Type DERIVED
PMID: 33590999 (View on PubMed)

Natale JE, Asaro LA, Joseph JG, Ulysse C, Ascenzi J, Bowens C, Wypij D, Curley MAQ; RESTORE Study Investigators. Association of Race and Ethnicity with Sedation Management in Pediatric Intensive Care. Ann Am Thorac Soc. 2021 Jan;18(1):93-102. doi: 10.1513/AnnalsATS.201912-872OC.

Reference Type DERIVED
PMID: 32776853 (View on PubMed)

Curley MAQ, Gedeit RG, Dodson BL, Amling JK, Soetenga DJ, Corriveau CO, Asario LA, Wypij D; RESTORE Investigative Team. Methods in the design and implementation of the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial. Trials. 2018 Dec 17;19(1):687. doi: 10.1186/s13063-018-3075-8.

Reference Type DERIVED
PMID: 30558653 (View on PubMed)

Watson RS, Asaro LA, Hertzog JH, Sorce LR, Kachmar AG, Dervan LA, Angus DC, Wypij D, Curley MAQ; RESTORE Study Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Long-Term Outcomes after Protocolized Sedation versus Usual Care in Ventilated Pediatric Patients. Am J Respir Crit Care Med. 2018 Jun 1;197(11):1457-1467. doi: 10.1164/rccm.201708-1768OC.

Reference Type DERIVED
PMID: 29313710 (View on PubMed)

Lebet R, Hayakawa J, Chamblee TB, Tala JA, Singh N, Wypij D, Curley MAQ. Maintaining Interrater Agreement of Core Assessment Instruments in a Multisite Randomized Controlled Clinical Trial: The Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) Trial. Nurs Res. 2017 Jul/Aug;66(4):323-329. doi: 10.1097/NNR.0000000000000224.

Reference Type DERIVED
PMID: 28654569 (View on PubMed)

Natale JE, Lebet R, Joseph JG, Ulysse C, Ascenzi J, Wypij D, Curley MAQ; Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) Study Investigators. Racial and Ethnic Disparities in Parental Refusal of Consent in a Large, Multisite Pediatric Critical Care Clinical Trial. J Pediatr. 2017 May;184:204-208.e1. doi: 10.1016/j.jpeds.2017.02.006. Epub 2017 Mar 2.

Reference Type DERIVED
PMID: 28410087 (View on PubMed)

Curley MA, Wypij D, Watson RS, Grant MJ, Asaro LA, Cheifetz IM, Dodson BL, Franck LS, Gedeit RG, Angus DC, Matthay MA; RESTORE Study Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators Network. Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial. JAMA. 2015 Jan 27;313(4):379-89. doi: 10.1001/jama.2014.18399.

Reference Type DERIVED
PMID: 25602358 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U01HL086622

Identifier Type: NIH

Identifier Source: secondary_id

View Link

U01HL086649

Identifier Type: NIH

Identifier Source: secondary_id

View Link

611

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The RELAX TO SLEEP Study
NCT01734148 COMPLETED NA